Keith Burkhart

2.4k total citations
66 papers, 1.4k citations indexed

About

Keith Burkhart is a scholar working on Emergency Medicine, Neurology and Pharmacology. According to data from OpenAlex, Keith Burkhart has authored 66 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Emergency Medicine, 10 papers in Neurology and 9 papers in Pharmacology. Recurrent topics in Keith Burkhart's work include Poisoning and overdose treatments (21 papers), Alcoholism and Thiamine Deficiency (8 papers) and Drug-Induced Hepatotoxicity and Protection (6 papers). Keith Burkhart is often cited by papers focused on Poisoning and overdose treatments (21 papers), Alcoholism and Thiamine Deficiency (8 papers) and Drug-Induced Hepatotoxicity and Protection (6 papers). Keith Burkhart collaborates with scholars based in United States, Netherlands and Germany. Keith Burkhart's co-authors include Jeffrey Brent, Kenneth Kulig, J. Ward Donovan, Kenneth E. McMartin, Ken Kulig, Scott Phillips, Paul I. Dargan, Barry H. Rumack, Toby Litovitz and Alan D. Woolf and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and PEDIATRICS.

In The Last Decade

Keith Burkhart

64 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Burkhart United States 22 496 242 190 187 129 66 1.4k
Marsha Ford United States 15 1.0k 2.1× 272 1.1× 142 0.7× 124 0.7× 183 1.4× 26 1.7k
Anthony F. Pizon United States 21 318 0.6× 107 0.4× 113 0.6× 153 0.8× 129 1.0× 82 1.1k
William Kerns United States 21 789 1.6× 179 0.7× 108 0.6× 191 1.0× 191 1.5× 36 1.5k
B. Zane Horowitz United States 25 446 0.9× 122 0.5× 176 0.9× 171 0.9× 251 1.9× 98 1.7k
Donna Seger United States 18 449 0.9× 113 0.5× 60 0.3× 140 0.7× 153 1.2× 49 1.1k
Blaine E. Benson United States 16 883 1.8× 177 0.7× 75 0.4× 92 0.5× 220 1.7× 33 1.6k
David D. Gummin United States 12 911 1.8× 245 1.0× 63 0.3× 133 0.7× 198 1.5× 25 1.7k
Barbara F. Schmitz United States 9 848 1.7× 173 0.7× 72 0.4× 104 0.6× 148 1.1× 11 1.6k
Kathleen M. Wruk United States 5 794 1.6× 209 0.9× 73 0.4× 88 0.5× 180 1.4× 7 1.2k
William G. Troutman United States 26 725 1.5× 254 1.0× 70 0.4× 96 0.5× 236 1.8× 43 1.7k

Countries citing papers authored by Keith Burkhart

Since Specialization
Citations

This map shows the geographic impact of Keith Burkhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Burkhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Burkhart more than expected).

Fields of papers citing papers by Keith Burkhart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Burkhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Burkhart. The network helps show where Keith Burkhart may publish in the future.

Co-authorship network of co-authors of Keith Burkhart

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Burkhart. A scholar is included among the top collaborators of Keith Burkhart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Burkhart. Keith Burkhart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Strauss, David G., Zhihua Li, Srikanth C. Nallani, et al.. (2024). Intranasal Naloxone Repeat Dosing Strategies and Fentanyl Overdose. JAMA Network Open. 7(1). e2351839–e2351839. 7 indexed citations
2.
Jackson, David, et al.. (2023). Rewiring Drug Research and Development through Human Data-Driven Discovery (HD3). Pharmaceutics. 15(6). 1673–1673. 1 indexed citations
3.
Konkel, Karen, et al.. (2023). Methanol poisonings from contaminated hand sanitizers identified by the United States Food and Drug Administration. Clinical Toxicology. 61(12). 1065–1067. 1 indexed citations
4.
Buchanan, Jennie, Jonathan Schimmel, Jeffrey Brent, et al.. (2023). Adverse Events in Pregnant Patients Treated with Coronavirus Disease 2019 Therapeutics. Journal of Medical Toxicology. 19(4). 381–388. 1 indexed citations
5.
Aldy, Kim, et al.. (2021). Rapid development of the FDA ACMT COVID-19 ToxIC (FACT) pharmacovigilance pilot project to monitor adverse events reported in association with COVID-19 therapeutics. Clinical Toxicology. 59(11). 1054–1054. 1 indexed citations
6.
Ellis, Christopher R., Rebecca Racz, Naomi L. Kruhlak, et al.. (2020). Evaluating kratom alkaloids using PHASE. PLoS ONE. 15(3). e0229646–e0229646. 41 indexed citations
7.
Rouse, Rodney, Naomi L. Kruhlak, James L. Weaver, et al.. (2017). Translating New Science Into the Drug Review Process: The US FDA’s Division of Applied Regulatory Science. Therapeutic Innovation & Regulatory Science. 52(2). 244–255. 17 indexed citations
8.
Sarntivijai, Sirarat, Shadia Zaman, Keith Burkhart, et al.. (2016). Linking MedDRA®-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors. Drug Safety. 39(7). 697–707. 21 indexed citations
9.
Ruha, Anne‐Michelle, Steven C. Curry, Benjamin J. Westenberger, et al.. (2012). Plasma and Urine Dimercaptopropanesulfonate Concentrations after Dermal Application of Transdermal DMPS (TD-DMPS). Journal of Medical Toxicology. 9(1). 9–15. 10 indexed citations
10.
Subbarao, Italo, Christopher Johnson, William F. Bond, et al.. (2005). Symptom-Based, Algorithmic Approach for Handling the Initial Encounter with Victims of a Potential Terrorist Attack. Prehospital and Disaster Medicine. 20(5). 301–308. 12 indexed citations
11.
Karl, Helen W., Charles J. Coté, Michael McCubbin, et al.. (1999). Intravenous midazolam for sedation of children undergoing procedures. Pediatric Emergency Care. 15(3). 167–172. 36 indexed citations
12.
Brent, Jeffrey, Kenneth E. McMartin, Scott Phillips, et al.. (1999). Fomepizole for the Treatment of Ethylene Glycol Poisoning. New England Journal of Medicine. 340(11). 832–838. 239 indexed citations
13.
Burkhart, Keith, et al.. (1999). Ethylene glycol and methanol poisoning: Diagnosis and treatment. Journal of Emergency Nursing. 25(2). 116–120. 1 indexed citations
14.
Burkhart, Keith, Daniel Carter Beard, Ralph A. W. Lehman, & Melvin L. Billingsley. (1998). Alterations in Tau Phosphorylation in Rat and Human Neocortical Brain Slices Following Hypoxia and Glucose Deprivation. Experimental Neurology. 154(2). 464–472. 41 indexed citations
15.
Shannon, Michael, Gary M. Albers, Keith Burkhart, et al.. (1997). Safety and efficacy of flumazenil in the reversal of benzodiazepine-induced conscious sedation. The Journal of Pediatrics. 131(4). 582–586. 88 indexed citations
16.
Burkhart, Keith, et al.. (1997). Naja naja cobra bite. The American Journal of Emergency Medicine. 15(5). 529–531. 11 indexed citations
17.
Woolf, Alan D., Keith Burkhart, Thomas R. Caraccio, & Toby Litovitz. (1996). Self-Poisoning Among Adults Using Multiple Transdermal Nicotine Patches. Journal of Toxicology Clinical Toxicology. 34(6). 691–698. 47 indexed citations
18.
Burkhart, Keith, et al.. (1992). The Adsorption of Isopropanol and Acetone by Activated Charcoal. Journal of Toxicology Clinical Toxicology. 30(3). 371–375. 9 indexed citations
19.
Burkhart, Keith. (1992). Intravenous Propranolol Reverses Hypertension after Sympathomimetic Overdose: Two Case Reports. Journal of Toxicology Clinical Toxicology. 30(1). 109–114. 9 indexed citations
20.
Burkhart, Keith, et al.. (1991). Hyperbaric Oxygen Treatment for Carbon Tetrachloride Poisoning. Drug Safety. 6(5). 332–338. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marsha Ford Breakdown of academic impact, for papers by Anthony F. Pizon Breakdown of academic impact, for papers by William Kerns Breakdown of academic impact, for papers by B. Zane Horowitz Breakdown of academic impact, for papers by Donna Seger Breakdown of academic impact, for papers by Blaine E. Benson Breakdown of academic impact, for papers by David D. Gummin Breakdown of academic impact, for papers by Barbara F. Schmitz Breakdown of academic impact, for papers by Kathleen M. Wruk Breakdown of academic impact, for papers by William G. Troutman
Rankless by CCL
2026